U.S. health officials have issued warnings on two separate Boston Scientific heart devices recently linked to injuries and ...

The FDA is reviewing Boston Scientific's defibrillator leads after reports of rising shock impedance and 16 related deaths.

While neither warning is classified as a recall, the FDA has provided additional information for the two products. Boston Scientific told customers that its Endotak Reliance defibrillation leads with ...

The update covers devices used in procedures to implant the company’s Watchman heart device.

The FDA has issued an early communication to warn of updated instructions for use for certain Boston Scientific Watchman access systems.

Boston Scientific is recommending updates to the instructions for use to minimize the issue, which has been tied to 17 deaths ...

A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the ...

Boston Scientific reported Q2 2025 sales of over $5bn, a 22.8% rise on Q2 2024, besting previous growth estimates of 19.5% at the high end.

Boston Scientific Corporation (NYSE:BSX) is one of the 13 Best Large Cap Stocks to Buy Right Now. On July 7, Boston Scientific Corporation (NYSE:BSX) announced that it has obtained approval to ...

The FDA has granted approval to a device made by Boston Scientific to treat atrial fibrillation, the company announced in a Jan. 31 news release. The pulsed field ablation system, called FaraPulse ...